INMED PHARMACEUTICALS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
INMED PHARMACEUTICALS INC. (INM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 32.54 thousand shares for the 12-month period ending 2026-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-09-09
- INMED PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 19.08K shares, a 4101.98% increase year-over-year.
- INMED PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 10.46K shares, a 1795.47% increase year-over-year.
- INMED PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 1.95K shares.
- INMED PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 1.05K shares.
- INMED PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 14.68K shares, a 22.05% increase from fiscal 2022.
- INMED PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 12.03K shares, a 68.24% decline from fiscal 2021.
- INMED PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2021 was 37.88K shares, a 40.05% decline from fiscal 2020.
- INMED PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2020 was 63.18K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 19.08K shares derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | 29.54K shares derived: sum of 2 quarters · filed 2026-09-09 | 31.48K shares derived: sum of 3 quarters · filed 2026-09-09 | 32.54K shares S-4/A · filed 2026-09-09 | |
| 2026-03-31 | 10.46K shares derived: S-4 9 month − 10-Q 6 month · filed 2026-07-02 | 12.41K shares derived: sum of 2 quarters · filed 2026-07-02 | 13.46K shares S-4 · filed 2026-07-02 | 13.92K shares derived: sum of 4 quarters · filed 2026-09-09 | |
| 2025-12-31 | 1.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-11 | 3.00K shares 10-Q · filed 2026-02-11 | 3.45K shares derived: sum of 3 quarters · filed 2026-09-09 | 4.00K shares derived: sum of 4 quarters · filed 2026-09-09 | |
| 2025-09-30 | 1.05K shares 10-Q · filed 2025-11-06 | 1.51K shares derived: sum of 2 quarters · filed 2026-09-09 | 2.06K shares derived: sum of 3 quarters · filed 2026-09-09 | ||
| 2025-06-30 | 454.00 shares derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-09 | 1.01K shares derived: sum of 2 quarters · filed 2026-09-09 | 1.01K shares S-4/A · filed 2026-09-09 | ||
| 2025-03-31 | 552.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-12 | 558.00 shares 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | 6.00 shares 10-Q · filed 2025-02-12 | ||||
| 2024-06-30 | 430.00 shares S-4 · filed 2026-07-02 | 8.57K shares 10-K · filed 2024-09-30 | |||
| 2023-12-31 | 848.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | 1.36K shares 10-Q · filed 2024-02-13 | 9.08K shares derived: sum of 3 quarters · filed 2024-09-30 | 12.19K shares derived: sum of 4 quarters · filed 2024-09-30 | |
| 2023-09-30 | 509.00 shares 10-Q · filed 2023-11-14 | 8.23K shares derived: sum of 2 quarters · filed 2024-09-30 | 11.35K shares derived: sum of 3 quarters · filed 2024-09-30 | 12.49K shares derived: sum of 4 quarters · filed 2024-09-30 | |
| 2023-06-30 | 7.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | 10.84K shares derived: sum of 2 quarters · filed 2024-09-30 | 11.98K shares derived: sum of 3 quarters · filed 2024-09-30 | 14.68K shares 10-K · filed 2024-09-30 | |
| 2023-03-31 | 3.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | 4.26K shares derived: sum of 2 quarters · filed 2023-05-15 | 6.96K shares 10-Q · filed 2023-05-15 | ||
| 2022-12-31 | 1.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-17 | 3.85K shares 10-Q · filed 2023-02-17 | |||
| 2022-09-30 | 2.70K shares 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | 12.03K shares 10-K · filed 2023-09-29 | ||||
| 2021-12-31 | 30.30K shares 10-Q · filed 2022-02-14 | ||||
| 2021-06-30 | 1.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-24 | 6.06K shares derived: sum of 2 quarters · filed 2021-09-24 | 267.46K shares 10-Q · filed 2022-05-13 | 37.88K shares 10-K · filed 2021-09-24 | |
| 2021-03-31 | 4.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | 4.55K shares derived: sum of 2 quarters · filed 2021-05-13 | 36.36K shares 10-Q · filed 2021-05-13 | ||
| 2020-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-11 | 31.82K shares 10-Q · filed 2021-02-11 | |||
| 2020-09-30 | 31.82K shares 10-Q · filed 2020-12-17 | ||||
| 2020-06-30 | 63.18K shares 10-K · filed 2021-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |